Merriman Wealth Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-26,000
| Closed | -$166K | – | 185 |
|
|
2020
Q1 | $166K | Buy |
26,000
+5,000
| +24% | +$31.9K | 0.04% | 146 |
|
|
2019
Q4 | $176K | Sell |
21,000
-1,000
| -5% | -$8.38K | 0.03% | 172 |
|
|
2019
Q3 | $199K | Buy |
22,000
+7,000
| +47% | +$63.3K | 0.04% | 166 |
|
|
2019
Q2 | $1.59K | Buy |
15,000
+5,000
| +50% | +$530 | 0.03% | 184 |
|
|
2019
Q1 | $95K | Hold |
10,000
| – | – | 0.02% | 203 |
|
|
2018
Q4 | $119K | Buy |
+10,000
| New | +$119K | 0.03% | 164 |
|